Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · IEX Real-Time Price · USD
3.390
+0.010 (0.30%)
At close: Jul 19, 2024, 4:00 PM
3.430
+0.040 (1.18%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Tenaya Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Tenaya Therapeutics stock have an average target of 15, with a low estimate of 7.00 and a high estimate of 20. The average target predicts an increase of 342.48% from the current stock price of 3.39.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TNYA stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +430.97% | Jul 8, 2024 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jun 10, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $18 → $16 | Strong Buy | Maintains | $18 → $16 | +371.98% | May 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +430.97% | May 15, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +489.97% | Mar 21, 2024 |
Financial Forecast
Revenue This Year
728.58K
Revenue Next Year
3.35M
from 728.58K
Increased by 359.94%
EPS This Year
-1.61
from -1.68
EPS Next Year
-1.58
from -1.61
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 5.3M | 15.8M | 77.5M | 544.6M | 1.7B |
| Avg | 728,576 | 3.4M | 41.7M | 230.7M | 828.4M |
| Low | n/a | n/a | n/a | 10.7M | 211.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 2,061.8% | 2,213.8% | 1,207.2% | 633.1% |
| Avg | - | 359.9% | 1,143.4% | 453.6% | 259.1% |
| Low | - | - | - | -74.2% | -8.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.24 | -1.17 | -0.86 | 3.42 | 10.83 |
| Avg | -1.61 | -1.58 | -1.49 | 0.15 | 4.34 |
| Low | -1.84 | -1.90 | -1.73 | -1.88 | -1.03 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 6,975.5% |
| Avg | - | - | - | - | 2,737.8% |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.